EPO and breast cancer: The most significant finding of this study was the confirmation of the anticancer activity of the natural product EPO; it potentiated the activity of the anticancer drug TAM against MCF-7 and MDA-MB-231 BC cell lines through the induction of apoptosis, inhibiting angiogenesis and arresting the cell cycle.